Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Phio Pharmaceuticals Corp. (PHIO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Phio Pharmaceuticals Corp. (PHIO), most recent 12 months reported: net loss $12.9M, free cash flow -$12.21M. Latest balance sheet on file: liquid cash $13M. From SEC filings. Others in Pharmaceutical Preparations: Oncotelic Therapeutics, Inc. · Processa Pharmaceuticals, Inc. · PDS Biotechnology Corporation · PEPGEN INC. · PROTOKINETIX, INCORPORATED · PLIANT THERAPEUTICS, INC. · Polaryx Therapeutics, Inc. · PROMIS NEUROSCIENCES INC.

Stock screener

Watchlist